Race to protect young brains: ICU sedation trial aims to stop delirium in critically ill kids
NCT ID NCT04801589
Summary
This study aims to find out which of two common sedative drugs is better for protecting brain function in infants and children who need a breathing machine in the intensive care unit. It will compare dexmedetomidine and midazolam in 372 young patients to see which one reduces delirium, shortens time on the ventilator, and leads to better long-term thinking skills and mental health recovery. The goal is to improve care for our most vulnerable young patients by choosing the medication that causes the least harm to the developing brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact
Conditions
Explore the condition pages connected to this study.